Abstract:Joanna Styszko, 1 Tomasz Kostrzewa, 1 Magdalena Gorska-Ponikowska, 1, 2 Alicja Kuban-Jankowska 1 1 Department of Medical Chemistry, Medical University of Gdansk, Gdansk, Poland; 2 Department of Biophysics, Institute of Biomaterials and Biomolecular Systems, University of Stuttgart, Stuttgart, Germany Correspondence: Alicja Kuban-Jankowska, Email Purpose: Citric acid (CA) is a tricarboxylic acid with antioxidant and antimicrobial properties. Based on previous studies, the small compound with its three carboxylic groups can be considered a protein tyrosine phosphatase inhibitor. YopH, a protein tyrosine phosphatase, is an essential virulence factor in Yersinia bacteria. Materials and Methods: We performed enzymatic activity assays of YopH phosphatase after treatment with citric acid in comparison with the inhibitory compound trimesic acid, which has a similar structure. We also measured the cytotoxicity of these compounds in Jurkat T E6.1 and macrophage J774.2 cell lines. We performed molecular docking analysis of the binding of citric acid molecules to YopH phosphatase. Results: Citric acid and trimesic acid reversibly reduced the activity of YopH enzyme and decreased the viability of Jurkat and macrophage cell lines. Importantly, these two compounds showed greater inhibitory properties against bacterial YopH activity than against human CD45 phosphatase activity. Molecular docking simulations confirmed that citric acid could bind to YopH phosphatase. Conclusion: Citric acid, a known antioxidant, can be considered an inhibitor of bacterial phosphatases. Keywords: protein tyrosine phosphatase, citric acid, trimesic acid, bacterial virulence factors, YopH, Yersinia , CD45 phosphatase Citric acid is a tricarboxylic acid with six carbons (Figure 1), which was first crystallized from lemon juice. It is a basic natural acid in citrus fruits and is found, for example, in limes, lemons, tomatoes, strawberries, strawberries, and cranberries. Interestingly, its production may also occur in the fungi Aspergillus niger and the yeast Yarrowia lipolytica . 1 Figure 1 Citric acid and trimesic acid formulas. Citric acid has been utilized as a preservative, but also has many other properties such as antioxidant, acidifying, and flavoring. 2,3 It has been established across many industries in the form of food, beverages, drugs, and beautifying products. Citric acid is highly soluble in water and quickly degrades through membranes. 3 Citric acid has been shown to exhibit superior antiviral effect. This causes irreversible damage to the virus. Accordingly, citric acid may be used for permanent disinfection of contaminated surfaces. 4 Citric acid possesses antimicrobial properties against bacteria transmitted through food, eg Escherichia coli, Salmonella, Listeria . 5 Yersinia enterocolitica is a bacterium that causes infections after consumption of undercooked meat products, unpasteurized milk, or water contaminated with bacteria. 6 The secretion of virulence factors is a characteristic phenomenon exploited by some virulent bacteria, such as Yersinia or Salmonella . Virulence effectors injected into host cells change signaling pathways and initiate the infection process. These virulence factors include bacterial protein tyrosine phosphatases, the activities of which are essential for bacterial pathogenicity. Yersinia spp. use a type III secretion model for the translocation of virulence effectors, such as YopH phosphatase. The protein tyrosine phosphatase YopH is involved in inhibiting phagocytosis by macrophages to eliminate pathogens. 7 Translocation of the bacterial YopH factor into phagocytic cell types inhibits the immune response of the infected host. YopH activates the disruption of focal adhesions 8,9 and inhibits phagocytosis. 10,11 This causes the release of tumor necrosis factors and oxidants. 12,13 YopH also impairs T-lymphocyte and B-lymphocyte function 14 at very early stages and prevents an adaptive inflammatory response crucial for the survival of bacteria in the lymph nodes of the host. 15 Previously, we reported that compounds possessing carboxylic acid groups in their structure may be considered potential inhibitors of protein tyrosine phosphatases. A compound with a structure similar to the most effective inhibitors known to date is aurintricarboxylic acid. 16,17 In this study, we analyzed the effect of citric acid in comparison to trimesic acid, which is also a promising inhibitory compound because of its small size and the presence -Abstract Truncated-

Tripeptide Inhibitors of Yersinia Protein-Tyrosine Phosphatase

Adhesive Properties of Yapv and Paralogous Autotransporter Proteins of Yersinia Pestis

Crystal Structure of the Yersinia Protein-Tyrosine Phosphatase YopH Complexed with a Specific Small Molecule Inhibitor.

Identification and Structure-Function Analyses of an Allosteric Inhibitor of the Tyrosine Phosphatase PTPN22.

Structural Basis for Inhibition of the Protein Tyrosine Phosphatase 1B by Phosphotyrosine Peptide Mimetics.

Citric Acid Controls the Activity of YopH Bacterial Tyrosine Phosphatase

On the potential pharmacophore for the structure-based inhibitor design against phosphatases

On the specificity of aurintricarboxylic acid toward some phosphatases

Y-shaped Bis-Arylethenesulfonic Acid Esters: Potential Potent and Membrane Permeable Protein Tyrosine Phosphatase 1B Inhibitors.

Highly Potent and Selective N-Aryl Oxamic Acid-Based Inhibitors for Mycobacterium Tuberculosis Protein Tyrosine Phosphatase B

Yersinia YopT Inhibits RLH‐mediated NF‐κB and IRF3 Signal Transduction

Screening of promising molecules against potential drug targets in Yersinia pestis by integrative pan and subtractive genomics, docking and simulation approach

Structure of the type III secretion and substrate-binding domain of Yersinia YopH phosphatase

Structure-Based Design and Synthesis of Small Molecule Protein-Tyrosine Phosphatase 1b Inhibitors

Yersinia pseudotuberculosis inhibits Fc receptor-mediated phagocytosis in J774 cells

Yersinia pestis Plasminogen Activator

Tautomycetin Synthetic Analogues: Selective Inhibitors of Protein Phosphatase I

Peptidomimetic analogues of an Arg-Trp-x-x-Trp motif responsible for interaction of translocase MraY with bacteriophage ϕX174 lysis protein E

Structure-Based Discovery of Small Molecule Inhibitors Targeted to Protein Tyrosine Phosphatase 1B

Synthesis of (Glycopyranosyl-Triazolyl)-purines and Their Inhibitory Activities Against Protein Tyrosine Phosphatase 1B (PTP1B)

Cellular Inhibition of Protein Tyrosine Phosphatase 1b by Uncharged Thioxothiazolidinone Derivatives